• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
BLT
Click for more information
5.77% 5.5¢

BENITEC BIOPHARMA LIMITED - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
BLT Appendix 3B07/03/19
BLT Appendix 4D and Half Year ReportPRICE SENSITIVE25/02/19
BLT Appendix 4C - quarterlyPRICE SENSITIVE31/01/19
BLT Benitec Provides Update on BB-401 Cancer Treatment ProgramPRICE SENSITIVE21/12/18
BLT Appendix 3B14/11/18
BLT Results of Meeting08/11/18
BLT Chairman's Presentation to ShareholdersPRICE SENSITIVE08/11/18
BLT Appendix 4C - quarterlyPRICE SENSITIVE29/10/18
BLT Notice of Annual General Meeting/Proxy Form05/10/18
BLT Benitec Appoints Senior Scientific Advisor19/09/18
BLT Appendix 3B18/09/18
BLT Appendix 4G and 2018 Corporate Governance Statement30/08/18
BLT Appendix 4E and 2018 Annual ReportPRICE SENSITIVE30/08/18
BLT Appendix 3B30/08/18
BLT Appendix 4C - quarterlyPRICE SENSITIVE31/07/18
BLT Ceasing to be a substantial holder11/07/18 download Created with Sketch. 70.19KB
BLT Benitec Announces Global Licensing Agreement with AxovantPRICE SENSITIVE09/07/18 download Created with Sketch. 262KB
BLT Trading HaltPRICE SENSITIVE09/07/18 download Created with Sketch. 828.04KB
BLT Company Secretary Appointment/Resignation29/06/18 download Created with Sketch. 373.2KB
BLT Updated Change in substantial holding18/06/18 download Created with Sketch. 242.72KB
BLT Benitec announces organisational restructure15/06/18 download Created with Sketch. 131.67KB
BLT Change in substantial holding15/06/18 download Created with Sketch. 81.58KB
BLT Change of Director's Interest Notice04/06/18 download Created with Sketch. 141.29KB
BLT Appendix 3B04/06/18 download Created with Sketch. 195.54KB
BLT COMPLETION OF ENTITLEMENT OFFER04/06/18 download Created with Sketch. 232.97KB
BLT CORPORATE PRESENTATION01/06/18 download Created with Sketch. 3.94MB
BLT QUARTERLY CORPORATE CALL TRANSCRIPT01/06/18 download Created with Sketch. 157.95KB
BLT EARNINGS REPORT FISCAL THIRD QUARTER 2018PRICE SENSITIVE31/05/18 download Created with Sketch. 273.2KB
BLT INTERIM REPORT NINE MONTHS TO 31 MARCH 2018PRICE SENSITIVE31/05/18 download Created with Sketch. 552.56KB
BLT ENTITLEMENT OFFER RESULTS AND UNDER-SUBSCRIPTIONS31/05/18 download Created with Sketch. 243.47KB
BLT Change of Director's Interest Notice30/05/18 download Created with Sketch. 93.2KB
BLT Change of Director's Interest Notice25/05/18 download Created with Sketch. 165.41KB
BLT QUARTERLY CORPORATE UPDATE CALL25/05/18 download Created with Sketch. 156.66KB
BLT PHASE 2 ONCOLOGY STUDY RUSSIAN APPROVALPRICE SENSITIVE24/05/18 download Created with Sketch. 243.3KB
BLT Appendix 3B18/05/18
BLT OPMD PRESENTATION AT ASGCT18/05/18
BLT INVESTOR WEBINAR ON OPMD TRANSCRIPT16/05/18
BLT INVESTOR WEBINAR ON OPMD SLIDES16/05/18
BLT OPMD DATA PRESENTATION AT ASGCT15/05/18
BLT Becoming a substantial holder09/05/18
BLT DISPATCH OF OFFER BOOKLET08/05/18
BLT Change in substantial holding07/05/18
BLT s708 CLEANSING STATEMENT07/05/18
BLT Appendix 3B04/05/18
BLT INVESTOR WEBINAR ON OPMD03/05/18
BLT INELIGIBLE SHAREHOLDERS LETTER01/05/18
BLT ELIGIBLE SHAREHOLDERS LETTER01/05/18
BLT ENTITLEMENT OFFER AND PLACEMENTPRICE SENSITIVE30/04/18
BLT ENTITLEMENT OFFER BOOKLETPRICE SENSITIVE30/04/18
BLT SECTION 708AA CLEANSING NOTICE30/04/18
BLT Appendix 4C - quarterlyPRICE SENSITIVE30/04/18
BLT Appendix 3B30/04/18
BLT Trading HaltPRICE SENSITIVE26/04/18
BLT Appendix 3B24/04/18
BLT CORPORATE PRESENTATION24/04/18
BLT CLINICAL PROGRAM UPDATEPRICE SENSITIVE24/04/18
BLT Appendix 3B12/04/18
BLT Appendix 3B21/03/18
BLT Presentation at ROTH Conference14/03/18
BLT BENITEC TO PRESENT AT ROTH CONFERENCE13/03/18
BLT PHASE 2 ONCOLOGY STUDY LAUNCHEDPRICE SENSITIVE05/03/18
BLT QUARTERLY CORPORATE CALL TRANSCRIPT23/02/18
BLT EARNINGS REPORT FISCAL SECOND QUARTER 201822/02/18
BLT Appendix 4D and Half Year ReportPRICE SENSITIVE22/02/18
BLT Quarterly Corporate Update Call14/02/18
BLT Appendix 4C - quarterlyPRICE SENSITIVE30/01/18
BLT RESEARCH & DEVELOPMENT GRANT RECEIVEDPRICE SENSITIVE23/01/18
BLT BENITEC RECEIVES US ORPHAN DESIGNATION FOR BB-301PRICE SENSITIVE15/01/18
BLT Appendix 3B09/01/18
BLT PRESENTATION AT BIOTECH SHOWCASE09/01/18
BLT BENITEC TO PRESENT AT BIOTECH SHOWCASE04/01/18
BLT Quarterly Corporate Call Transcript30/11/17
BLT Earnings Report First Fiscal Quarter 2018PRICE SENSITIVE29/11/17
BLT Interim Report 3 Months to 30 September 2017PRICE SENSITIVE29/11/17
BLT OPMD Orphan Disease Program UpdatePRICE SENSITIVE27/11/17
BLT Quarterly Corporate Update Call23/11/17
BLT Benitec Corporate Presentation22/11/17
BLT Appendix 3B17/11/17
BLT Results of Meeting08/11/17
BLT Chairman and CEO Address to Shareholders08/11/17
BLT Appendix 4C - quarterlyPRICE SENSITIVE30/10/17
BLT Final Director's Interest Notice24/10/17
BLT DIRECTOR RESIGNATION23/10/17
BLT Response to ASX Query LetterPRICE SENSITIVE23/10/17
BLT US PATENT GRANTED FOR HEPATITIS B PROGRAMPRICE SENSITIVE18/10/17
BLT APPOINTMENT OF NEW CHAIRMAN12/10/17
BLT RESIGNATION OF CHIEF BUSINESS OFFICER10/10/17
BLT Annual Report to shareholders09/10/17
BLT Notice of Annual General Meeting/Proxy Form09/10/17
BLT BENITEC TO PRESENT AT WMS AND ESGCT04/10/17
BLT BENITEC TO PRESENT AT CELL & GENE MEETING28/09/17
BLT BENITEC PRESENTS AT R&R INVESTMENT CONFERENCE11/09/17
BLT Appendix 3B07/09/17
BLT Change of Director's Interest Notice07/09/17
BLT QUARTERLY CORPORATE CALL TRANSCRIPT30/08/17
BLT EARNINGS REPORT FOURTH FISCAL QUARTER 201729/08/17
BLT Appendix 4G and Corporate Governance29/08/17
BLT Appendix 4E and Annual ReportPRICE SENSITIVE29/08/17
BLT BENITEC TO PRESENT AT R&R INVESTMENT CONFERENCE23/08/17
BLT QUARTERLY CORPORATE UPDATE CALL22/08/17
BLT Appendix 3B
07/03/19
BLT Appendix 4D and Half Year Report
25/02/19PRICE SENSITIVE
BLT Appendix 4C - quarterly
31/01/19PRICE SENSITIVE
BLT Benitec Provides Update on BB-401 Cancer Treatment Program
21/12/18PRICE SENSITIVE
BLT Appendix 3B
14/11/18
BLT Results of Meeting
08/11/18
BLT Chairman's Presentation to Shareholders
08/11/18PRICE SENSITIVE
BLT Appendix 4C - quarterly
29/10/18PRICE SENSITIVE
BLT Notice of Annual General Meeting/Proxy Form
05/10/18
BLT Benitec Appoints Senior Scientific Advisor
19/09/18
BLT Appendix 3B
18/09/18
BLT Appendix 4G and 2018 Corporate Governance Statement
30/08/18
BLT Appendix 4E and 2018 Annual Report
30/08/18PRICE SENSITIVE
BLT Appendix 3B
30/08/18
BLT Appendix 4C - quarterly
31/07/18PRICE SENSITIVE
BLT Ceasing to be a substantial holder
11/07/18 download Created with Sketch. 70.19KB
BLT Benitec Announces Global Licensing Agreement with Axovant
09/07/18PRICE SENSITIVE download Created with Sketch. 262KB
BLT Trading Halt
09/07/18PRICE SENSITIVE download Created with Sketch. 828.04KB
BLT Company Secretary Appointment/Resignation
29/06/18 download Created with Sketch. 373.2KB
BLT Updated Change in substantial holding
18/06/18 download Created with Sketch. 242.72KB
BLT Benitec announces organisational restructure
15/06/18 download Created with Sketch. 131.67KB
BLT Change in substantial holding
15/06/18 download Created with Sketch. 81.58KB
BLT Change of Director's Interest Notice
04/06/18 download Created with Sketch. 141.29KB
BLT Appendix 3B
04/06/18 download Created with Sketch. 195.54KB
BLT COMPLETION OF ENTITLEMENT OFFER
04/06/18 download Created with Sketch. 232.97KB
BLT CORPORATE PRESENTATION
01/06/18 download Created with Sketch. 3.94MB
BLT QUARTERLY CORPORATE CALL TRANSCRIPT
01/06/18 download Created with Sketch. 157.95KB
BLT EARNINGS REPORT FISCAL THIRD QUARTER 2018
31/05/18PRICE SENSITIVE download Created with Sketch. 273.2KB
BLT INTERIM REPORT NINE MONTHS TO 31 MARCH 2018
31/05/18PRICE SENSITIVE download Created with Sketch. 552.56KB
BLT ENTITLEMENT OFFER RESULTS AND UNDER-SUBSCRIPTIONS
31/05/18 download Created with Sketch. 243.47KB
BLT Change of Director's Interest Notice
30/05/18 download Created with Sketch. 93.2KB
BLT Change of Director's Interest Notice
25/05/18 download Created with Sketch. 165.41KB
BLT QUARTERLY CORPORATE UPDATE CALL
25/05/18 download Created with Sketch. 156.66KB
BLT PHASE 2 ONCOLOGY STUDY RUSSIAN APPROVAL
24/05/18PRICE SENSITIVE download Created with Sketch. 243.3KB
BLT Appendix 3B
18/05/18
BLT OPMD PRESENTATION AT ASGCT
18/05/18
BLT INVESTOR WEBINAR ON OPMD TRANSCRIPT
16/05/18
BLT INVESTOR WEBINAR ON OPMD SLIDES
16/05/18
BLT OPMD DATA PRESENTATION AT ASGCT
15/05/18
BLT Becoming a substantial holder
09/05/18
BLT DISPATCH OF OFFER BOOKLET
08/05/18
BLT Change in substantial holding
07/05/18
BLT s708 CLEANSING STATEMENT
07/05/18
BLT Appendix 3B
04/05/18
BLT INVESTOR WEBINAR ON OPMD
03/05/18
BLT INELIGIBLE SHAREHOLDERS LETTER
01/05/18
BLT ELIGIBLE SHAREHOLDERS LETTER
01/05/18
BLT ENTITLEMENT OFFER AND PLACEMENT
30/04/18PRICE SENSITIVE
BLT ENTITLEMENT OFFER BOOKLET
30/04/18PRICE SENSITIVE
BLT SECTION 708AA CLEANSING NOTICE
30/04/18
BLT Appendix 4C - quarterly
30/04/18PRICE SENSITIVE
BLT Appendix 3B
30/04/18
BLT Trading Halt
26/04/18PRICE SENSITIVE
BLT Appendix 3B
24/04/18
BLT CORPORATE PRESENTATION
24/04/18
BLT CLINICAL PROGRAM UPDATE
24/04/18PRICE SENSITIVE
BLT Appendix 3B
12/04/18
BLT Appendix 3B
21/03/18
BLT Presentation at ROTH Conference
14/03/18
BLT BENITEC TO PRESENT AT ROTH CONFERENCE
13/03/18
BLT PHASE 2 ONCOLOGY STUDY LAUNCHED
05/03/18PRICE SENSITIVE
BLT QUARTERLY CORPORATE CALL TRANSCRIPT
23/02/18
BLT EARNINGS REPORT FISCAL SECOND QUARTER 2018
22/02/18
BLT Appendix 4D and Half Year Report
22/02/18PRICE SENSITIVE
BLT Quarterly Corporate Update Call
14/02/18
BLT Appendix 4C - quarterly
30/01/18PRICE SENSITIVE
BLT RESEARCH & DEVELOPMENT GRANT RECEIVED
23/01/18PRICE SENSITIVE
BLT BENITEC RECEIVES US ORPHAN DESIGNATION FOR BB-301
15/01/18PRICE SENSITIVE
BLT Appendix 3B
09/01/18
BLT PRESENTATION AT BIOTECH SHOWCASE
09/01/18
BLT BENITEC TO PRESENT AT BIOTECH SHOWCASE
04/01/18
BLT Quarterly Corporate Call Transcript
30/11/17
BLT Earnings Report First Fiscal Quarter 2018
29/11/17PRICE SENSITIVE
BLT Interim Report 3 Months to 30 September 2017
29/11/17PRICE SENSITIVE
BLT OPMD Orphan Disease Program Update
27/11/17PRICE SENSITIVE
BLT Quarterly Corporate Update Call
23/11/17
BLT Benitec Corporate Presentation
22/11/17
BLT Appendix 3B
17/11/17
BLT Results of Meeting
08/11/17
BLT Chairman and CEO Address to Shareholders
08/11/17
BLT Appendix 4C - quarterly
30/10/17PRICE SENSITIVE
BLT Final Director's Interest Notice
24/10/17
BLT DIRECTOR RESIGNATION
23/10/17
BLT Response to ASX Query Letter
23/10/17PRICE SENSITIVE
BLT US PATENT GRANTED FOR HEPATITIS B PROGRAM
18/10/17PRICE SENSITIVE
BLT APPOINTMENT OF NEW CHAIRMAN
12/10/17
BLT RESIGNATION OF CHIEF BUSINESS OFFICER
10/10/17
BLT Annual Report to shareholders
09/10/17
BLT Notice of Annual General Meeting/Proxy Form
09/10/17
BLT BENITEC TO PRESENT AT WMS AND ESGCT
04/10/17
BLT BENITEC TO PRESENT AT CELL & GENE MEETING
28/09/17
BLT BENITEC PRESENTS AT R&R INVESTMENT CONFERENCE
11/09/17
BLT Appendix 3B
07/09/17
BLT Change of Director's Interest Notice
07/09/17
BLT QUARTERLY CORPORATE CALL TRANSCRIPT
30/08/17
BLT EARNINGS REPORT FOURTH FISCAL QUARTER 2017
29/08/17
BLT Appendix 4G and Corporate Governance
29/08/17
BLT Appendix 4E and Annual Report
29/08/17PRICE SENSITIVE
BLT BENITEC TO PRESENT AT R&R INVESTMENT CONFERENCE
23/08/17
BLT QUARTERLY CORPORATE UPDATE CALL
22/08/17
refresh Created with Sketch. REFRESH
 

Top Stories

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s. 
Titan Minerals hits 2m @ 32g/t gold from surface in trenching at Cerro Verde - but shares fall Titan Minerals (ASX:TTM) has reported hitting a brief trenching intersection of only 2m width but from surface and at 32g/t gold.
Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025 Samples among the highest-ever-graded uranium soil samples recorded in mineral exploration history, and an imminent drill run.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.